Genemedi produces core diagnostic ingredients for test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome. GeneMedi offers paired diagnostics grade cancer antigen 125 (CA-125) antibodies (monoclonal antibody, mab) and antigens for Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) rapid test kit of cancer antigen 125 (CA-125) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers. ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in symptomatic women presenting to primary care. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood. A CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease. A CA 125 test isn’t accurate enough to use for ovarian cancer screening in general because many noncancerous conditions can increase the CA 125 level. Many different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.